BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN
44151 results:

  • 1. Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis.
    Schindler P; Kaldewey D; Rennebaum F; Trebicka J; Pascher A; Wildgruber M; Köhler M; Masthoff M
    J Cancer Res Clin Oncol; 2024 May; 150(5):235. PubMed ID: 38710956
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinoma.
    Howell TC; Rhodin KE; Shaw B; Bao J; Kanu E; Masoud S; Bartholomew AJ; Gao Q; Anwar IJ; Ladowski JM; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Barbas AS; Lidsky ME
    J Gastrointest Surg; 2024 May; 28(5):738-745. PubMed ID: 38704208
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study.
    Wei G; Zhao Y; Feng S; Yuan J; Xu G; Lv T; Yang J; Kong L; Yang J
    BMC Cancer; 2024 May; 24(1):558. PubMed ID: 38702621
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis.
    Hu J; Shao Y; Gui C; Xiao Y; Li L; Li Z
    Medicine (Baltimore); 2024 May; 103(18):e38007. PubMed ID: 38701269
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors.
    Sun W; Yin X; Liu X; Wei J; Yu M; Li W; Ding X; Chen J
    Front Immunol; 2024; 15():1380477. PubMed ID: 38698848
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluation of TikTok videos on acute pancreatitis: content quality and reliability analysis.
    Mao T; Zhao X; Jiang K; Yang J; Xie Q; Fu J; Du B; Lei Z; Gao F
    BMC Public Health; 2024 May; 24(1):1216. PubMed ID: 38698404
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Expression of Fascin-1 and its diagnostic value in liver cancer.
    Lu SP; Jiang LJ; Wang Y; Shao JK; Du ZQ; Huang BF; Wang CQ
    Sci Rep; 2024 May; 14(1):10049. PubMed ID: 38698008
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Predicting response of hepatoblastoma primary lesions to neoadjuvant chemotherapy through contrast-enhanced computed tomography radiomics.
    Yang Y; Wang H; Si J; Zhang L; Ding H; Wang F; He L; Chen X
    J Cancer Res Clin Oncol; 2024 Apr; 150(5):223. PubMed ID: 38691204
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The application of a single-hand-operated hepatic pedicle clamping clamp in laparoscopic hepatectomy.
    Shen Z; Jiang B; Chu H; Wang G; Fang X; Chen Z; Yang Y; Wang J; Wang X
    Langenbecks Arch Surg; 2024 Apr; 409(1):146. PubMed ID: 38691172
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.
    Zeng TM; Jiang TY; Yang G; Cheng Z; Lou C; Wei W; Tao CJ; Hu S; Wang H; Cui XW; Tan YX; Dong LW; Wang HY; Yuan ZG
    Clin Transl Med; 2024 May; 14(5):e1675. PubMed ID: 38689424
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia.
    Valery PC; Roche S; Brown C; O'Beirne J; Hartel G; Leggett B; Skoien R; Powell EE
    Int J Equity Health; 2024 Apr; 23(1):84. PubMed ID: 38689295
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A Comparative Analysis of Implant-sparing Plan
    Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
    In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma.
    Yamaba S; Imai Y; Sugawara K; Uchida Y; Fuchigami A; Uchiya H; Nakayama N; Mochida S
    PLoS One; 2024; 19(4):e0298770. PubMed ID: 38687817
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Risk factors associated with lymph node metastasis in early-stage distal gastric cancer.
    Yu Z; Liang C; Li R; Gao J; Gao Y; Zhou S; Li P
    World J Surg; 2024 Jan; 48(1):151-162. PubMed ID: 38686759
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma.
    Fu S; Xu Y; Mao Y; He M; Chen Z; Huang S; Li D; Lv Y; Wu J
    Cancer Med; 2024 May; 13(9):e7105. PubMed ID: 38686567
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma.
    Zhu JQ; Liu JZ; Yang SW; Ren ZY; Ye XY; Liu Z; Li XL; Han DD; He Q
    Front Endocrinol (Lausanne); 2024; 15():1306091. PubMed ID: 38686208
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).
    Saberzadeh-Ardestani B; Khosravi AA; Mansour-Ghanaei F; Vahedi H; Baniasadi N; Seyyedmajidi M; Parhizkar B; Hormati A; Naghshbandi SJ; Matin S; Hassan Zadeh AA; Taghvaei T; Bahrami M; Rafeey M; Ahadi M; Vossoughinia H; Muosavi H; Gheibi S; Hosseini-Hemmatabadi RS; Yazdanbod A; Matinkhah S; Sheikh Esmaeili F; Fakheri H; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Farahmand F; Najafi M; Alimadadi H; Malekzadeh M; Anushiravani A; Kasaeian A; Alatab S; Sadeghi A; Radmard AR; Kolahdoozan S; Rajabi Z; Sima AR
    Arch Iran Med; 2024 Apr; 27(4):183-190. PubMed ID: 38685844
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. No-Touch Radiofrequency Ablation Using Twin Cooled Wet Electrodes for Recurrent Hepatocellular Carcinoma Following Locoregional Treatments.
    Hong SJ; Kim JH; Yoon JH; Park JH; Yoon JH; Kim YJ; Yu SJ; Cho EJ; Lee JM
    Korean J Radiol; 2024 May; 25(5):438-448. PubMed ID: 38685734
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer.
    Liu X; Ren B; Fang Y; Ren J; Wang X; Gu M; Zhou F; Xiao R; Luo X; You L; Zhao Y
    J Transl Med; 2024 Apr; 22(1):393. PubMed ID: 38685045
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
    Daher D; Seif El Dahan K; Rich NE; Tayob N; Merrill V; Huang DQ; Yang JD; Kulkarni AV; Kanwal F; Marrero J; Parikh N; Singal AG
    JAMA Netw Open; 2024 Apr; 7(4):e248755. PubMed ID: 38683607
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2208.